(Q44395638)

2 December 2017

title

Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine (English)

1 reference

2 December 2017

1 reference

1 reference

1 reference

1

A Barbeau

1 reference

2 December 2017

T Cloutier

2

1 reference

2 December 2017

M Roy

3

1 reference

2 December 2017

L Plasse

4

1 reference

2 December 2017

S Paris

5

1 reference

2 December 2017

J Poirier

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 November 1985

1 reference

2 December 2017

1 reference

2 December 2017

volume

2

1 reference

2 December 2017

issue

8466

1 reference

2 December 2017

page(s)

1213-1216

1 reference

Parkinson's disease. A genetic study

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Aetiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Etiology of Parkinson's disease: A research strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Clinical ecogenetics: cancer in families.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

A prospective study of 50 cases of familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Association between essential tremor and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

The heterogeneity of Parkinson's disease: clinical and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Parkinson's disease in 65 pairs of twins and in a set of quadruplets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Neurological consequence of industrial exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

A survey of drug-induced extrapyramidal reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Manganese in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

The Metabolism of Insecticides: The Role of Monooxygenase Enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Potent induction of human placental mono-oxygenase activity by previous dietary exposure to polychlorinated biphenyls and their thermal degradation products

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

The metabolism of [14C]-debrisoquine in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

A population and familial study of the defective alicyclic hydroxylation of debrisoquine among Egyptians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Polymorphic hydroxylation of debrisoquine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and Orientals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Debrisoquin hydroxylation polymorphism among Ghanaians and Caucasians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

A human cytochrome P-450 characterized by inhibition studies as the sparteine-debrisoquine monooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Oxidation phenotype--a major determinant of metoprolol metabolism and response

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Individual Differences in the Disposition of Drugs Metabolised in the Body

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Impaired oxidation of debrisoquine in patients with perhexiline liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2990743-3

7 January 2021

10.1016/S0140-6736(85)90743-3

Identifiers

DOI

1 reference

2 December 2017

1 reference